1 (888) 402-3465

Episode 13: Advantages of Telehealth with Dr. Suzanne Shugg

Jun 21, 2018

Summary

Dr. Suzanne Shugg, CEO and Co-Founder of Teleplus Healthcare, teaches us how telehealth is helping battle hurdles of compliance and education, especially in the rural and senior communities.

Here are some of the interview highlights:

  • What do telehealth and telemedicine mean, and what are their differences?
  • The advantages of bringing telehealth for managing chronic care and rural health.
  • The motivations behind the creation of the telehealth company and its continued success.

In this episode

Dr. Suzanne Shugg, CEO & Co-Founder of Teleplus Healthcare

Teleplus is a medical information technology company that combines comprehensive telemedicine and tele-educational services with the leading treatment technology, focusing on the areas of Sleep Apnea, Congestive Heart Failure, Obesity, Chronic Care, and COPD. Teleplus has an exclusive global partnership with the University of Pennsylvania called the UPENN Sleep Disorder Certificate program that distributes sleep disorder education.

Suzanne Shugg, DNP, has over 20 years of experience in multiple healthcare sectors. She has developed a new, innovative health insurance company, implemented and expanded preventive cardiovascular clinics, assisted in the management of hospital systems, and remains a hands-on health care provider.

Suzanne continues to teach all aspects of Adult Medicine and Future Technology in Medicine at Rutgers University, where her program is ranked 7th in the U.S. As a pioneer in telemedicine, she has implemented telemedical services in hospital systems, clinical settings, and doctors’ offices. She was elected as a Fellow of the National Lipid Association, one of the highest and most prestigious rankings in the organization.

Suzanne was the Director of Preventive Cardiovascular Services at a large multi-specialty medical group, where under her direction the clinic grew to out produce any other clinic in New Jersey. She has practiced various aspects of cardiology in and out of hospital settings and established a preventive clinic.

Suzanne currently heads a preventive clinic at a partner of the largest hospital system in New Jersey, Saint Barnabas Medical Center and New Jersey Cardiology Associates. She has served across the United States as a consultant for telemedicine, starting independent telemedicine clinics both in and out of hospitals. She has been published in numerous peer-reviewed journals, sits on multiple medical boards and is a highly sought-after speaker in the field of preventive cardiology and telemedicine.

John Marchica

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He was the founder and CEO of FaxWatch, a leading business intelligence and medical education company and two-time member of the Inc. 500 list of America's fastest growing companies.

John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade. John earned his B.A. in economics from Knox College, an MBA and M.A. in public policy from The University of Chicago, and completed his Ph.D. coursework and doctoral exams in clinical epidemiology and health economics at The Dartmouth Institute for Health Policy and Clinical Practice. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

share

Request a Call from Darwin Research Group and we will get right back to you.